Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

690
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
690

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 infection produces an IL-33-dependent chronic eosinophilic pneumonia and muco-inflammatory airways disease in mice.

JCI insight·2026
Same author

Menstruation is associated with cyclical granulysin peaks in vaginal secretions despite stable expression by cervicovaginal immune cells.

bioRxiv : the preprint server for biology·2026
Same author

Improve genetic quality control to increase rigor and reproducibility of mouse research.

Science (New York, N.Y.)·2026
Same author

Regulatory T cells restrain IL-15-mediated cytotoxic and bystander T cell activity in mucosal tissue without compromising antigen-driven memory.

bioRxiv : the preprint server for biology·2026
Same author

Initiation of oral pre-exposure prophylaxis associated with changes in genital tract T cell phenotypes in women exposed to HIV.

The Journal of infectious diseases·2026
Same author

Cross-coronavirus host susceptibility loci influence disease severity through immune mediators.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 5, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.2K

Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.

Jessica B Graham1, Jessica L Swarts1, Vineet D Menachery2,3

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

The Journal of Infectious Diseases
|October 18, 2019
PubMed
Summary
This summary is machine-generated.

Identifying immune system traits before infection can predict severe outcomes from viruses like influenza. This discovery aids in early intervention and improved vaccine development for at-risk individuals.

Keywords:
Collaborative CrossRNA virus infectionimmune correlates of mortality

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.0K

Related Experiment Videos

Last Updated: Jan 5, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.2K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.0K

Area of Science:

  • Immunology
  • Virology
  • Genetics

Background:

  • Viral infections cause a spectrum of disease severity, from mild to fatal.
  • Emerging and re-emerging viral outbreaks, alongside common infections like influenza, pose ongoing global health challenges.
  • Preventing severe disease is hindered by a lack of effective vaccines and difficulty in identifying high-risk individuals early.

Purpose of the Study:

  • To identify pre-infection immune correlates of protection against mortality from viral infections.
  • To leverage natural variation in disease susceptibility within a genetically diverse mouse model.
  • To inform strategies for early clinical intervention and vaccine design.

Main Methods:

  • Infection of Collaborative Cross (CC) mice with influenza, severe acute respiratory syndrome-coronavirus, and West Nile virus.
  • Observation and categorization of disease manifestations, including mortality and survival.
  • Comprehensive pre-infection immunophenotyping to identify immune system characteristics.

Main Results:

  • CC mice displayed a wide range of responses to viral infections, with some strains experiencing mortality and others showing no mortality.
  • Pre-infection immunophenotyping revealed distinct immune profiles associated with protection from mortality.
  • Natural variation in disease outcomes was observed across different CC mouse strains.

Conclusions:

  • Pre-infection immune phenotypes can potentially identify individuals at higher risk of severe outcomes from viral infections.
  • These findings may guide the development of targeted clinical interventions for high-risk populations.
  • Immune profiles could provide insights for more rational and effective vaccine design.